STAT

As patients tell apps they’re feeling suicidal, digital health startups scramble to respond

Patients are increasingly confessing suicidal thoughts using communication tools designed to help them manage their diabetes or figure out why they might have a headache.

SAN FRANCISCO — Digital health apps, which let patients chat with doctors or health coaches or even receive likely medical diagnoses from a bot, are transforming modern health care. They are also — in practice — being used as suicide crisis hotlines.

Patients are confessing suicidal thoughts using apps designed to help them manage their diabetes or figure out why they might have a headache, according to industry executives. As a result, many digital health startups are scrambling to figure out how best to respond and when to call the police — questions that even suicide prevention experts don’t have good answers to.

“To be honest, when we started this, I didn’t think it was as big an issue as it obviously is,” said Daniel Nathrath, CEO of Ada Health.

The European company built a chatbot to provide smartphone

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks